- Home
- VIR vs AMSF Comparison
VIR vs AMSF Comparison
Compare VIR & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- AMSF
- Stock Information
- Founded
- VIR 2016
- AMSF 1985
- Country
- VIR United States
- AMSF United States
- Employees
- VIR N/A
- AMSF N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- AMSF Accident &Health Insurance
- Sector
- VIR Health Care
- AMSF Finance
- Exchange
- VIR Nasdaq
- AMSF Nasdaq
- Market Cap
- VIR 844.9M
- AMSF 918.6M
- IPO Year
- VIR 2019
- AMSF 2005
- Fundamental
- Price
- VIR $5.07
- AMSF $47.63
- Analyst Decision
- VIR Strong Buy
- AMSF Buy
- Analyst Count
- VIR 7
- AMSF 2
- Target Price
- VIR $32.86
- AMSF $59.50
- AVG Volume (30 Days)
- VIR 1.6M
- AMSF 77.1K
- Earning Date
- VIR 05-07-2025
- AMSF 07-28-2025
- Dividend Yield
- VIR N/A
- AMSF 9.49%
- EPS Growth
- VIR N/A
- AMSF N/A
- EPS
- VIR N/A
- AMSF 2.48
- Revenue
- VIR $20,861,000.00
- AMSF $301,216,000.00
- Revenue This Year
- VIR N/A
- AMSF $1.69
- Revenue Next Year
- VIR $15.32
- AMSF $6.54
- P/E Ratio
- VIR N/A
- AMSF $19.21
- Revenue Growth
- VIR N/A
- AMSF N/A
- 52 Week Low
- VIR $4.32
- AMSF $41.97
- 52 Week High
- VIR $14.45
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- VIR 47.79
- AMSF 50.38
- Support Level
- VIR $4.72
- AMSF $45.80
- Resistance Level
- VIR $5.24
- AMSF $48.54
- Average True Range (ATR)
- VIR 0.32
- AMSF 0.97
- MACD
- VIR 0.09
- AMSF 0.16
- Stochastic Oscillator
- VIR 70.09
- AMSF 66.79
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums.